Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "daily"

484 News Found

Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool
Digitisation | May 24, 2022

Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool

The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs


Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections
News | May 24, 2022

Glenmark launches Whatsapp based chatbot-‘Hello Skin’ for patients suffering from fungal infections

'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)


Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device
Healthcare | May 23, 2022

Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device

Objective tracking data combined with cohort data to drive medicine of the future


CHMP recommends European Commission approval of Rinvoq
Drug Approval | May 23, 2022

CHMP recommends European Commission approval of Rinvoq

Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients


Neurocrine Biosciences receives Orphan Drug Designation for Valbenazine
Biotech | May 13, 2022

Neurocrine Biosciences receives Orphan Drug Designation for Valbenazine

The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation


All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week
News | May 13, 2022

All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week

As part of the celebrations, the Institute organised a series of activities in the run up to International Nurses Day which is observed on 12th May every year


USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19
Drug Approval | May 12, 2022

USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19

Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19


Alembic Pharmaceuticals receives USFDA  approval for Arformoterol Tartrate
Drug Approval | May 11, 2022

Alembic Pharmaceuticals receives USFDA approval for Arformoterol Tartrate

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies


Lupin selects HPE GreenLake edge-to-cloud platform
Digitisation | May 09, 2022

Lupin selects HPE GreenLake edge-to-cloud platform

Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss


Procter & Gamble Health posts 14 per cent growth in net profit in Q3
Biotech | May 06, 2022

Procter & Gamble Health posts 14 per cent growth in net profit in Q3

The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year